| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.5 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |